<DOC>
	<DOC>NCT01902290</DOC>
	<brief_summary>The purpose of this study is to determine if brodalumab (AMG 827) is safe and effective compared to placebo as measured by change in Asthma Control Questionnaire (ACQ) composite scores.</brief_summary>
	<brief_title>Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Bronchodilator Agents</mesh_term>
	<criteria>Diagnosis of asthma, and presently has reversibility over prebronchodilator FEV1 of ≥ 20% at screening Percent of predicted FEV1 ≥ 40% and ≤ 80% at screening ICS ≥ 200 and ≤ 1000/μg/day fluticasone powder or equivalent Ongoing asthma symptoms with ACQ composite score at screening and baseline ≥ 1.5 points History of chronic obstructive pulmonary disease or other chronic pulmonary condition other than asthma History of allergic bronchopulmonary aspergillosis Respiratory infection within 4 weeks of screening or 1 week of baseline visit Subject has known history of Crohn's disease Subject has any other significant concurrent medical condition of laboratory abnormalities, as defined in the study protocol Subject has previously used any antiIL17 biologic therapy Subject is pregnant or breastfeeding, or planning to become pregnant while enrolled in the study Female subject is unwilling to use highly effective methods of birth control unless 2 years postmenopausal or surgically sterile Subject has severe depression measured by Personal Health Questionnaire Depression Scale (PHQ8) or suicidal ideation/behavior as measured by and Columbia Suicide Severity Rating Scale (eCSSRS) Subject has a history or evidence of psychiatric disorder or substance abuse considered by the Investigator to pose a risk to subject safety</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Inadequately controlled asthma, brodalumab, AMG 827</keyword>
</DOC>